Clinical Characteristics and Risk of Relapse for Patients with Stage I–II Diffuse Large B-cell Lymphoma Treated in First Line with Immunochemotherapy by S. Mercadal, F. Climent, E. Domingo-Doménech, A. Oliveira, V. Romagosa, A. Fernández de Sevilla, E. González-Barca

Get full text

PB2125: LYMPHOMATOID PAPULOSIS-LIKE (LYP-LIKE) AFTER BRENTUXIMAB VEDOTIN-CHP (BV-CHP) TREATMENT FOR ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL) by P. Lopez Pereira, O. Servitje, F. Climent, E. Domingo-Domenech, A. Oliveira, C. Muniesa, A. Sureda, E. González-Barca

Get full text

20598. ANGIOGÉNESIS EN LA NEUROTOXICIDAD PERIFÉRICA INDUCIDA POR QUIMIOTERAPIA (NPIQ): EXPLORANDO EL VEGF CIRCULANTE COMO BIOMARCADOR DEL DESARROLLO Y RECUPERACIÓN DE LA NPIQ by R. Velasco Fargas, P. Andrés Benito, C. Marco Cazcarra, S. Roca Pereira, A. Pros Marsal, Y. López Sampere, E. Domingo Domènech, C. Santos, A. Stradella, J. Bruna Escuer

Get full text

P1083: BRENTUXIMAB VEDOTIN, ETOPOSIDE, SOLUMEDROL, HIGH DOSE ARA-C & PLATINUM FOLLOWED BY HDT & APBSCT FOR REFRACTORY/RELAPSED HODGKIN LYMPHOMA PATIENTS: LONG-TERM RESULTS OF THE G... by R. Garcia-Sanz, C. Martínez, F. De la Cruz, A. P. González, A. Rodríguez, B. Sánchez-González, E. Domingo-Domenech, M. Moreno, J. López, J. L. Piñana, M. Bastos, M. Canales, A. Gutiérrez, M. J. Rodríguez-Salazar, A. Navarro, A. Sureda

Get full text

P1260: UNRAVELING THE GENETICS OF TRANSFORMED SPLENIC MARGINAL ZONE LYMPHOMA by M. Grau, C. López, A. Navarro, G. Clot, F. Nadeu, G. Bastidas, M. Alcoceba, M. J. Baptista, M. Blanes, F. Climent, D. Colomer, D. Costa, E. Domingo-Domènech, P. Forcada, A. Enjuanes, L. Escoda, G. Frigola, E. Giné, M. Lopez-Guerra, A. Rivas-Delgado, L. Vicente-Folch, A. Wotherspoon, E. Campo, A. López-Guillermo, E. Matutes, S. Beà

Get full text